Rights and permissions
About this article
Cite this article
Tamoxifen cost effective for primary breast cancer prevention. Pharmacoecon. Outcomes News 350, 7 (2002). https://doi.org/10.1007/BF03278695
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03278695